Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amiloride for Edema in Nephrotic Syndrome
NCT05079789Phase 3Terminated
- Sponsor
- University Hospital Tübingen
- Start
- Jun 2020
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amiloride in nephrotic syndrome, sponsored by University Hospital Tübingen. Started Jun 2020; status: terminated.
02
Drugs
amiloride
03
Conditions
nephrotic syndrome
Beyond the preview
Go deeper on NCT05079789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05079789.